Evidence map›Paper›PMID 26025962›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2015

Comparative Analysis of T Cell Imaging with Human Nuclear Reporter Genes.

Maxim A Moroz, Hanwen Zhang, Jason Lee, Ekaterina Moroz, Juan Zurita, Larissa Shenker, Inna Serganova, Ronald Blasberg, Vladimir Ponomarev

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 77 citations in OpenAlex.

  1. Review
  2. Article
  3. Finding Your CAR: The Road Ahead for Engineered T Cells.The American journal of pathology · 2024
    Review
  4. Noninvasive longitudinal PET/CT imaging of CAR T cells using PSMA reporter gene.European journal of nuclear medicine and molecular imaging · 2024
    Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Evaluation of [Molecular imaging · 2022
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Maxim A MorozDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Hanwen ZhangDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Jason LeeCrump Institute for Molecular Imaging, University of California, Los Angeles, California.
Ekaterina MorozDepartment of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York; and.
Juan ZuritaDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Larissa ShenkerDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Inna SerganovaDepartment of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York; and.
Ronald BlasbergDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York; and Sloan Kettering Institute Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Vladimir PonomarevDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York Sloan Kettering Institute Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York ponomarv@mskcc.org.
Memorial Sloan Kettering Cancer Center · USUniversity of California, Los Angeles · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Tumor Evolution and Changes in MetabolismP50CA086438 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI RIVIERI, ISABELLE · 2000 to 2015
$29.9M
Tumor microenvironment: Impact on T cell tumor-targeting, activation and survivalR01CA163980 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI BLASBERG, RONALD GEORGE, PONOMAREV, VLADIMIR · 2012 to 2016
$2.5M
Imaging T-cell Activation and Co-stimulation in Prostate Cancer ImmunotherapyR01CA161138 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI PONOMAREV, VLADIMIR · 2011 to 2015
$1.9M
PET Imaging of Tumor Targeting &Role of T LymphocytesR01CA102352 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI PONOMAREV, VLADIMIR · 2005 to 2008
$1.3M
NanoSPECT/CT for Oncology ResearchS10RR028889 · NCRR · SLOAN-KETTERING INST CAN RESEARCH · PI ZANZONICO, PAT B · 2011 to 2011
$907k
SHARED INSTRUMENT: FOCUS MICROPET: CANCERS10RR020892 · NCRR · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI LARSON, STEVEN MARK · 2005 to 2005
$499k
NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA08748NCI NIH HHS P50 CA086438NCI NIH HHS P50 CA86438-11NCI NIH HHS R01 CA102352NCI NIH HHS R01 CA161138NCI NIH HHS R01 CA163980NCRR NIH HHS 1 S10 RR020892-01NCRR NIH HHS 1 S10 RR028889-01NCRR NIH HHS S10 RR020892NCRR NIH HHS S10 RR028889
6 · The paper itself

Abstract

unlabelledMonitoring genetically altered T cells is an important component of adoptive T cell therapy in patients, and the ability to visualize their trafficking/targeting, proliferation/expansion, and retention/death using highly sensitive reporter systems that do not induce an immunologic response would provide useful information. Therefore, we focused on human reporter gene systems that have the potential for translation to clinical studies. The objective of the in vivo imaging studies was to determine the minimum number of T cells that could be visualized with the different nuclear reporter systems. We determined the imaging sensitivity (lower limit of T cell detection) of each reporter using appropriate radiolabeled probes for PET or SPECT imaging.

methodsHuman T cells were transduced with retroviral vectors encoding for the human norepinephrine transporter (hNET), human sodium-iodide symporter (hNIS), a human deoxycytidine kinase double mutant (hdCKDM), and herpes simplex virus type 1 thymidine kinase (hsvTK) reporter genes. After viability and growth were assessed, 10(5) to 3 × 10(6) reporter T cells were injected subcutaneously on the shoulder area. The corresponding radiolabeled probe was injected intravenously 30 min later, followed by sequential PET or SPECT imaging. Radioactivity at the T cell injection sites and in the thigh (background) was measured.

resultsThe viability and growth of experimental cells were unaffected by transduction. The hNET/meta-(18)F-fluorobenzylguanidine ((18)F-MFBG) reporter system could detect less than 1 × 10(5) T cells because of its high uptake in the transduced T cells and low background activity. The hNIS/(124)I-iodide reporter system could detect approximately 1 × 10(6) T cells; (124)I-iodide uptake at the T cell injection site was time-dependent and associated with high background. The hdCKDM/2'-(18)F-fluoro-5-ethyl-1-β-d-arabinofuranosyluracil ((18)F-FEAU) and hsvTK/(18)F-FEAU reporter systems detected approximately 3 × 10(5) T cells, respectively. (18)F-FEAU was a more efficient probe (higher uptake, lower background) than (124)I-1-(2-deoxy-2-fluoro-1-d-arabinofuranosyl)-5-iodouracil for both hdCKDM and hsvTK.

conclusionA comparison of different reporter gene-reporter probe systems for imaging of T cell number was performed, and the hNET/(18)F-MFBG PET reporter system was found to be the most sensitive and capable of detecting approximately 35-40 × 10(3) T cells at the site of T cell injection in the animal model.

Indexed as

Genes, ReporterAnimalsArabinofuranosyluracilCell SurvivalFluorine RadioisotopesFluorobenzenesGuanidinesHerpesvirus 1, HumanHumansImmunotherapyMaleMiceMice, NudeMutationNeoplasm TransplantationNorepinephrine Plasma Membrane Transport Proteins2'-fluoro-5-ethylarabinosyluracil3-fluorobenzylguanidineArabinofuranosyluracilFluorine RadioisotopesFluorobenzenesGuanidinesNorepinephrine Plasma Membrane Transport ProteinsSodium-Iodide SymportersSymportersThymidine KinaseimagingPETreporter genesT cells

Identifiers

PMID26025962
PMCPMC4511596
OpenAlexW2227964207

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.